Is QDEL or NEOG more profitable?

Neogen has a net margin of -0.91% compared to QuidelOrtho's net margin of -39.20%. QuidelOrtho's return on equity of 4.88% beat Neogen's return on equity. Company Net Margins Return on Equity Return on Assets QuidelOrtho -39.20% 4.88% 1.63% Neogen -0.91% 2.78% 1.74%

Does the media favor QDEL or NEOG?

In the previous week, QuidelOrtho had 6 more articles in the media than Neogen. MarketBeat recorded 9 mentions for QuidelOrtho and 3 mentions for Neogen. Neogen's average media sentiment score of 1.23 beat QuidelOrtho's score of 0.40 indicating that Neogen is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment QuidelOrtho 3 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Neogen 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend QDEL or UFPT?

QuidelOrtho currently has a consensus price target of $13.63, suggesting a potential downside of 5.97%. Given QuidelOrtho's higher probable upside, analysts clearly believe QuidelOrtho is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score QuidelOrtho 3 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media refer more to QDEL or UFPT?

In the previous week, UFP Technologies had 8 more articles in the media than QuidelOrtho. MarketBeat recorded 17 mentions for UFP Technologies and 9 mentions for QuidelOrtho. UFP Technologies' average media sentiment score of 0.98 beat QuidelOrtho's score of 0.40 indicating that UFP Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment QuidelOrtho 3 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral UFP Technologies 12 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to QDEL or XRAY?

In the previous week, QuidelOrtho had 5 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 9 mentions for QuidelOrtho and 4 mentions for DENTSPLY SIRONA. DENTSPLY SIRONA's average media sentiment score of 1.01 beat QuidelOrtho's score of 0.40 indicating that DENTSPLY SIRONA is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment QuidelOrtho 3 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral DENTSPLY SIRONA 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend QDEL or AVNS?

QuidelOrtho currently has a consensus price target of $13.63, suggesting a potential downside of 5.97%. Given QuidelOrtho's higher possible upside, equities research analysts plainly believe QuidelOrtho is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score QuidelOrtho 3 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media refer more to QDEL or AVNS?

In the previous week, QuidelOrtho had 5 more articles in the media than Avanos Medical. MarketBeat recorded 9 mentions for QuidelOrtho and 4 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.31 beat QuidelOrtho's score of 0.40 indicating that Avanos Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment QuidelOrtho 3 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Avanos Medical 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation & earnings, QDEL or CERS?

Cerus has lower revenue, but higher earnings than QuidelOrtho. Cerus is trading at a lower price-to-earnings ratio than QuidelOrtho, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio QuidelOrtho $2.73B 0.36 -$1.13B -$15.41 N/A Cerus $206.13M 2.63 -$15.63M -$0.03 N/A

Is QDEL or CERS more profitable?

Cerus has a net margin of -3.06% compared to QuidelOrtho's net margin of -39.20%. QuidelOrtho's return on equity of 4.88% beat Cerus' return on equity. Company Net Margins Return on Equity Return on Assets QuidelOrtho -39.20% 4.88% 1.63% Cerus -3.06% -10.19% -3.14%

Does the media refer more to QDEL or CERS?

In the previous week, QuidelOrtho had 4 more articles in the media than Cerus. MarketBeat recorded 9 mentions for QuidelOrtho and 5 mentions for Cerus. Cerus' average media sentiment score of 0.71 beat QuidelOrtho's score of 0.40 indicating that Cerus is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment QuidelOrtho 3 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Cerus 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

QuidelOrtho (QDEL) Competitors

$14.49 -0.25 (-1.70%)

Closing price 04:00 PM Eastern

Extended Trading

$14.49 0.00 (0.00%)

As of 04:41 PM Eastern

Compare

QDEL vs. NEOG, UFPT, XRAY, AVNS, and CERS

Should you buy QuidelOrtho stock or one of its competitors? QuidelOrtho's main competitors and comparable companies include Neogen (NEOG), UFP Technologies (UFPT), DENTSPLY SIRONA (XRAY), Avanos Medical (AVNS), and Cerus (CERS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does QuidelOrtho compare to Neogen?

QuidelOrtho (NASDAQ:QDEL) and Neogen (NASDAQ:NEOG) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, earnings, profitability, dividends, risk, institutional ownership, media sentiment and analyst recommendations.

QuidelOrtho has a beta of 0.68, indicating that its share price is 32% less volatile than the broader market. Comparatively, Neogen has a beta of 1.77, indicating that its share price is 77% more volatile than the broader market.

In the previous week, QuidelOrtho had 6 more articles in the media than Neogen. MarketBeat recorded 9 mentions for QuidelOrtho and 3 mentions for Neogen. Neogen's average media sentiment score of 1.23 beat QuidelOrtho's score of 0.40 indicating that Neogen is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
QuidelOrtho	3 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Neogen	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

QuidelOrtho presently has a consensus price target of $13.63, indicating a potential downside of 5.97%. Neogen has a consensus price target of $11.67, indicating a potential upside of 0.57%. Given Neogen's stronger consensus rating and higher probable upside, analysts clearly believe Neogen is more favorable than QuidelOrtho.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
QuidelOrtho	3 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Neogen	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

99.0% of QuidelOrtho shares are owned by institutional investors. Comparatively, 96.7% of Neogen shares are owned by institutional investors. 1.1% of QuidelOrtho shares are owned by company insiders. Comparatively, 0.6% of Neogen shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Neogen has a net margin of -0.91% compared to QuidelOrtho's net margin of -39.20%. QuidelOrtho's return on equity of 4.88% beat Neogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
QuidelOrtho	-39.20%	4.88%	1.63%
Neogen	-0.91%	2.78%	1.74%

Neogen has lower revenue, but higher earnings than QuidelOrtho. Neogen is trading at a lower price-to-earnings ratio than QuidelOrtho, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
QuidelOrtho	$2.73B	0.36	-$1.13B	-$15.41	N/A
Neogen	$870.40M	2.91	-$7.90M	-$0.03	N/A

Summary

Neogen beats QuidelOrtho on 10 of the 16 factors compared between the two stocks.

How does QuidelOrtho compare to UFP Technologies?

QuidelOrtho (NASDAQ:QDEL) and UFP Technologies (NASDAQ:UFPT) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, media sentiment, analyst recommendations and dividends.

QuidelOrtho has a beta of 0.68, suggesting that its stock price is 32% less volatile than the broader market. Comparatively, UFP Technologies has a beta of 1.08, suggesting that its stock price is 8% more volatile than the broader market.

QuidelOrtho currently has a consensus price target of $13.63, suggesting a potential downside of 5.97%. Given QuidelOrtho's higher probable upside, analysts clearly believe QuidelOrtho is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
QuidelOrtho	3 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

UFP Technologies has lower revenue, but higher earnings than QuidelOrtho. QuidelOrtho is trading at a lower price-to-earnings ratio than UFP Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
QuidelOrtho	$2.73B	0.36	-$1.13B	-$15.41	N/A
UFP Technologies	$602.80M	3.93	$68.31M	$9.28	32.91

UFP Technologies has a net margin of 11.45% compared to QuidelOrtho's net margin of -39.20%. UFP Technologies' return on equity of 18.42% beat QuidelOrtho's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
QuidelOrtho	-39.20%	4.88%	1.63%
UFP Technologies	11.45%	18.42%	11.96%

99.0% of QuidelOrtho shares are owned by institutional investors. Comparatively, 87.3% of UFP Technologies shares are owned by institutional investors. 1.1% of QuidelOrtho shares are owned by company insiders. Comparatively, 4.6% of UFP Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, UFP Technologies had 8 more articles in the media than QuidelOrtho. MarketBeat recorded 17 mentions for UFP Technologies and 9 mentions for QuidelOrtho. UFP Technologies' average media sentiment score of 0.98 beat QuidelOrtho's score of 0.40 indicating that UFP Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
QuidelOrtho	3 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
UFP Technologies	12 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

UFP Technologies beats QuidelOrtho on 12 of the 15 factors compared between the two stocks.

How does QuidelOrtho compare to DENTSPLY SIRONA?

QuidelOrtho (NASDAQ:QDEL) and DENTSPLY SIRONA (NASDAQ:XRAY) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, analyst recommendations, earnings, media sentiment and risk.

DENTSPLY SIRONA has a net margin of -14.99% compared to QuidelOrtho's net margin of -39.20%. DENTSPLY SIRONA's return on equity of 20.84% beat QuidelOrtho's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
QuidelOrtho	-39.20%	4.88%	1.63%
DENTSPLY SIRONA	-14.99%	20.84%	5.32%

In the previous week, QuidelOrtho had 5 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 9 mentions for QuidelOrtho and 4 mentions for DENTSPLY SIRONA. DENTSPLY SIRONA's average media sentiment score of 1.01 beat QuidelOrtho's score of 0.40 indicating that DENTSPLY SIRONA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
QuidelOrtho	3 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
DENTSPLY SIRONA	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

DENTSPLY SIRONA has higher revenue and earnings than QuidelOrtho. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than QuidelOrtho, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
QuidelOrtho	$2.73B	0.36	-$1.13B	-$15.41	N/A
DENTSPLY SIRONA	$3.68B	0.59	-$598M	-$2.75	N/A

99.0% of QuidelOrtho shares are held by institutional investors. Comparatively, 95.7% of DENTSPLY SIRONA shares are held by institutional investors. 1.1% of QuidelOrtho shares are held by insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

QuidelOrtho has a beta of 0.68, meaning that its share price is 32% less volatile than the broader market. Comparatively, DENTSPLY SIRONA has a beta of 0.85, meaning that its share price is 15% less volatile than the broader market.

QuidelOrtho presently has a consensus target price of $13.63, suggesting a potential downside of 5.97%. DENTSPLY SIRONA has a consensus target price of $13.54, suggesting a potential upside of 24.32%. Given DENTSPLY SIRONA's stronger consensus rating and higher probable upside, analysts clearly believe DENTSPLY SIRONA is more favorable than QuidelOrtho.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
QuidelOrtho	3 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
DENTSPLY SIRONA	3 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

DENTSPLY SIRONA beats QuidelOrtho on 12 of the 16 factors compared between the two stocks.

How does QuidelOrtho compare to Avanos Medical?

QuidelOrtho (NASDAQ:QDEL) and Avanos Medical (NYSE:AVNS) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.

QuidelOrtho has a beta of 0.68, meaning that its stock price is 32% less volatile than the broader market. Comparatively, Avanos Medical has a beta of 1.57, meaning that its stock price is 57% more volatile than the broader market.

99.0% of QuidelOrtho shares are held by institutional investors. Comparatively, 95.2% of Avanos Medical shares are held by institutional investors. 1.1% of QuidelOrtho shares are held by company insiders. Comparatively, 2.3% of Avanos Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, QuidelOrtho had 5 more articles in the media than Avanos Medical. MarketBeat recorded 9 mentions for QuidelOrtho and 4 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.31 beat QuidelOrtho's score of 0.40 indicating that Avanos Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
QuidelOrtho	3 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Avanos Medical	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Avanos Medical has a net margin of -10.39% compared to QuidelOrtho's net margin of -39.20%. Avanos Medical's return on equity of 5.39% beat QuidelOrtho's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
QuidelOrtho	-39.20%	4.88%	1.63%
Avanos Medical	-10.39%	5.39%	3.97%

QuidelOrtho currently has a consensus price target of $13.63, suggesting a potential downside of 5.97%. Given QuidelOrtho's higher possible upside, equities research analysts plainly believe QuidelOrtho is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
QuidelOrtho	3 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Avanos Medical has lower revenue, but higher earnings than QuidelOrtho. Avanos Medical is trading at a lower price-to-earnings ratio than QuidelOrtho, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
QuidelOrtho	$2.73B	0.36	-$1.13B	-$15.41	N/A
Avanos Medical	$715.90M	1.64	-$72.90M	-$1.61	N/A

Summary

Avanos Medical beats QuidelOrtho on 9 of the 14 factors compared between the two stocks.

How does QuidelOrtho compare to Cerus?

QuidelOrtho (NASDAQ:QDEL) and Cerus (NASDAQ:CERS) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability.

QuidelOrtho has a beta of 0.68, suggesting that its stock price is 32% less volatile than the broader market. Comparatively, Cerus has a beta of 1.81, suggesting that its stock price is 81% more volatile than the broader market.

99.0% of QuidelOrtho shares are held by institutional investors. Comparatively, 78.4% of Cerus shares are held by institutional investors. 1.1% of QuidelOrtho shares are held by insiders. Comparatively, 5.3% of Cerus shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Cerus has lower revenue, but higher earnings than QuidelOrtho. Cerus is trading at a lower price-to-earnings ratio than QuidelOrtho, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
QuidelOrtho	$2.73B	0.36	-$1.13B	-$15.41	N/A
Cerus	$206.13M	2.63	-$15.63M	-$0.03	N/A

In the previous week, QuidelOrtho had 4 more articles in the media than Cerus. MarketBeat recorded 9 mentions for QuidelOrtho and 5 mentions for Cerus. Cerus' average media sentiment score of 0.71 beat QuidelOrtho's score of 0.40 indicating that Cerus is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
QuidelOrtho	3 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cerus	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

QuidelOrtho presently has a consensus target price of $13.63, suggesting a potential downside of 5.97%. Cerus has a consensus target price of $4.00, suggesting a potential upside of 48.70%. Given Cerus' stronger consensus rating and higher possible upside, analysts clearly believe Cerus is more favorable than QuidelOrtho.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
QuidelOrtho	3 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Cerus	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Cerus has a net margin of -3.06% compared to QuidelOrtho's net margin of -39.20%. QuidelOrtho's return on equity of 4.88% beat Cerus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
QuidelOrtho	-39.20%	4.88%	1.63%
Cerus	-3.06%	-10.19%	-3.14%

Summary

Cerus beats QuidelOrtho on 10 of the 16 factors compared between the two stocks.

Get QuidelOrtho News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QDEL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

QDEL vs. The Competition

Export

Metric	QuidelOrtho	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$993.58M	$5.84B	$7.30B	$12.71B
Dividend Yield	N/A	1.75%	2.54%	10.79%
P/E Ratio	-0.94	26.18	271.39	24.11
Price / Sales	0.36	69.66	604.56	77.78
Price / Cash	0.78	33.71	29.03	36.90
Price / Book	0.51	6.18	11.18	6.40
Net Income	-$1.13B	$149.30M	$3.46B	$348.28M
7 Day Performance	-0.62%	0.93%	1.97%	0.95%
1 Month Performance	-9.72%	8.87%	7.30%	5.15%
1 Year Performance	-48.06%	7.30%	24.74%	16.18%

QuidelOrtho Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
QDEL QuidelOrtho	1.4135 of 5 stars	$14.49 -1.7%	$13.63 -6.0%	-47.2%	$993.58M	$2.73B	N/A	6,500
NEOG Neogen	2.5038 of 5 stars	$11.87 +1.9%	$11.67 -1.7%	+111.9%	$2.54B	$870.40M	N/A	2,110	Positive News
UFPT UFP Technologies	2.2454 of 5 stars	$321.31 -0.1%	N/A	+36.9%	$2.49B	$602.80M	34.62	5,349	News Coverage Positive News
XRAY DENTSPLY SIRONA	4.5871 of 5 stars	$11.19 -3.5%	$13.38 +19.6%	-25.5%	$2.31B	$3.68B	N/A	14,000	Positive News Analyst Forecast
AVNS Avanos Medical	1.2444 of 5 stars	$24.99 flat	N/A	N/A	$1.17B	$715.90M	N/A	2,287	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:QDEL) was last updated on 8/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

QuidelOrtho (QDEL) Competitors

QDEL vs. NEOG, UFPT, XRAY, AVNS, and CERS

How does QuidelOrtho compare to Neogen?

Summary

How does QuidelOrtho compare to UFP Technologies?

Summary

How does QuidelOrtho compare to DENTSPLY SIRONA?

Summary

How does QuidelOrtho compare to Avanos Medical?

Summary

How does QuidelOrtho compare to Cerus?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QDEL vs. The Competition

QuidelOrtho Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

QuidelOrtho (QDEL) Competitors

QDEL vs. NEOG, UFPT, XRAY, AVNS, and CERS

How does QuidelOrtho compare to Neogen?

Which has more volatility and risk, QDEL or NEOG?

Does the media favor QDEL or NEOG?

Do analysts rate QDEL or NEOG?

Do institutionals and insiders have more ownership in QDEL or NEOG?

Is QDEL or NEOG more profitable?

Which has stronger earnings and valuation, QDEL or NEOG?

Summary

How does QuidelOrtho compare to UFP Technologies?

Which has more volatility & risk, QDEL or UFPT?

Do analysts recommend QDEL or UFPT?

Which has higher valuation & earnings, QDEL or UFPT?

Is QDEL or UFPT more profitable?

Do insiders & institutionals hold more shares of QDEL or UFPT?

Does the media refer more to QDEL or UFPT?

Summary

How does QuidelOrtho compare to DENTSPLY SIRONA?

Is QDEL or XRAY more profitable?

Does the media refer more to QDEL or XRAY?

Which has better valuation and earnings, QDEL or XRAY?

Do institutionals and insiders hold more shares of QDEL or XRAY?

Which has more risk & volatility, QDEL or XRAY?

Do analysts rate QDEL or XRAY?

Summary

How does QuidelOrtho compare to Avanos Medical?

Which has more volatility and risk, QDEL or AVNS?

Do institutionals and insiders hold more shares of QDEL or AVNS?

Does the media refer more to QDEL or AVNS?

Is QDEL or AVNS more profitable?

Do analysts recommend QDEL or AVNS?

Which has stronger valuation and earnings, QDEL or AVNS?

Summary

How does QuidelOrtho compare to Cerus?

Which has more volatility & risk, QDEL or CERS?

Do institutionals and insiders believe in QDEL or CERS?

Which has preferable valuation & earnings, QDEL or CERS?

Does the media refer more to QDEL or CERS?

Do analysts prefer QDEL or CERS?

Is QDEL or CERS more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QDEL vs. The Competition

QuidelOrtho Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools